SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-23-000217
Filing Date
2023-02-14
Accepted
2023-02-14 16:30:36
Documents
1
Group Members
SHAY CAPITAL HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 e618259_sc13ga-pharmacyte.htm SC 13G/A 71972
  Complete submission text file 0001193805-23-000217.txt   73709
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Subject) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: SC 13G/A | Act: 34 | File No.: 005-91495 | Film No.: 23630166
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 280 PARK AVENUE, 5TH FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE, 5TH FLOOR WEST NEW YORK NY 10017 6465610434
Shay Capital LLC (Filed by) CIK: 0001723643 (see all company filings)

IRS No.: 822647087 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A